price
KR
NASDAQ · KROS
Keros Therapeutics, Inc.
Healthcare · Biotechnology
$11.36
Up+$0.62 (+5.77%)
Updated Sep 18, 2026, 9:08 AM
SID Score
6.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 878.88M
- P/E ratio
- 13.67
- Dividend yield
- 0.00%
- 52-week range
- $9.69 – $12.65
- Volume
- 274.09K
- Avg. volume
- 987.56K
Price performance
KROS price history
1M range · 20 trading sessions · Daily adjusted prices
KROS closed at $11.36 after 20 trading sessions, up 3.74% for the selected period.
- Last close
- $11.36
- Period change
- +3.74%
- Period low
- $10.74
- Period high
- $11.68
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $10.87 | $11.39 | $10.83 | $11.36 | 274.09K |
| Sep 16, 2026 | $11.23 | $11.23 | $10.70 | $10.74 | 273.99K |
| Sep 15, 2026 | $11.16 | $11.21 | $10.72 | $11.17 | 199.98K |
| Sep 14, 2026 | $11.10 | $11.34 | $10.98 | $11.21 | 342.16K |
| Sep 11, 2026 | $11.25 | $11.34 | $11.025 | $11.08 | 143.83K |
| Sep 10, 2026 | $11.16 | $11.20 | $11.00 | $11.17 | 128.79K |
| Sep 9, 2026 | $11.475 | $11.82 | $11.21 | $11.31 | 188.51K |
| Sep 8, 2026 | $11.16 | $11.31 | $10.98 | $11.17 | 73.05K |
| Sep 4, 2026 | $11.03 | $11.40 | $11.02 | $11.32 | 65.64K |
| Sep 3, 2026 | $11.27 | $11.32 | $10.9173 | $11.11 | 148.71K |
| Sep 2, 2026 | $11.07 | $11.49 | $10.97 | $11.23 | 97.97K |
| Sep 1, 2026 | $11.02 | $11.125 | $10.83 | $11.07 | 96.24K |
| Aug 31, 2026 | $10.93 | $11.195 | $10.76 | $11.08 | 179.96K |
| Aug 28, 2026 | $11.15 | $11.16 | $10.58 | $11.03 | 328.29K |
| Aug 27, 2026 | $11.09 | $11.475 | $11.01 | $11.23 | 127.58K |
| Aug 26, 2026 | $11.66 | $11.66 | $11.08 | $11.12 | 113.6K |
| Aug 25, 2026 | $10.83 | $11.71 | $10.83 | $11.68 | 200.32K |
| Aug 24, 2026 | $11.12 | $11.12 | $10.72 | $10.78 | 217.08K |
| Aug 21, 2026 | $10.96 | $11.09 | $10.805 | $11.03 | 157.51K |
| Aug 20, 2026 | $11.09 | $11.10 | $10.55 | $10.95 | 203.07K |
Latest KROS news
The latest Smart Investors Daily articles mentioning KROS.
Stock researchMarket Activity · Institutional Ownership
Loading stock research…